Arild Harboe

523 total citations
42 papers, 422 citations indexed

About

Arild Harboe is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Arild Harboe has authored 42 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Arild Harboe's work include Influenza Virus Research Studies (8 papers), Animal Disease Management and Epidemiology (7 papers) and Toxoplasma gondii Research Studies (6 papers). Arild Harboe is often cited by papers focused on Influenza Virus Research Studies (8 papers), Animal Disease Management and Epidemiology (7 papers) and Toxoplasma gondii Research Studies (6 papers). Arild Harboe collaborates with scholars based in United States, Norway and Netherlands. Arild Harboe's co-authors include Gunnar Haukenes, Calderón Howe, B. P. Berdal, A Lystad, Eirik Holten, K Bøvre, Peter Gaustad, Tov Omland, L O Frøholm and E. Arne Høiby and has published in prestigious journals such as Nature, The Journal of Immunology and Journal of Bacteriology.

In The Last Decade

Arild Harboe

38 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arild Harboe United States 12 180 145 79 67 64 42 422
M V Lancaster United States 7 187 1.0× 93 0.6× 122 1.5× 7 0.1× 20 0.3× 9 475
Yolanta Fishman Israel 13 227 1.3× 113 0.8× 199 2.5× 43 0.6× 28 0.4× 16 486
Michael H. Ivey United States 11 333 1.9× 29 0.2× 53 0.7× 98 1.5× 4 0.1× 30 514
Dolf Evenberg Netherlands 13 128 0.7× 205 1.4× 234 3.0× 9 0.1× 65 1.0× 18 513
Sara T. Méndez Mexico 15 142 0.8× 140 1.0× 29 0.4× 200 3.0× 3 0.0× 29 613
S. K. Dutta United States 14 98 0.5× 151 1.0× 101 1.3× 183 2.7× 36 515
Osvaldo Zábal Argentina 15 178 1.0× 120 0.8× 78 1.0× 29 0.4× 5 0.1× 28 494
S H Parry United Kingdom 12 43 0.2× 118 0.8× 47 0.6× 47 0.7× 1 0.0× 13 324
Silvia Camprubí Spain 13 140 0.8× 153 1.1× 241 3.1× 9 0.1× 18 0.3× 26 639
Patricia W. Harris-Smith United States 14 55 0.3× 267 1.8× 54 0.7× 23 0.3× 2 0.0× 18 481

Countries citing papers authored by Arild Harboe

Since Specialization
Citations

This map shows the geographic impact of Arild Harboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arild Harboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arild Harboe more than expected).

Fields of papers citing papers by Arild Harboe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arild Harboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arild Harboe. The network helps show where Arild Harboe may publish in the future.

Co-authorship network of co-authors of Arild Harboe

This figure shows the co-authorship network connecting the top 25 collaborators of Arild Harboe. A scholar is included among the top collaborators of Arild Harboe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arild Harboe. Arild Harboe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berdal, B. P., Peter Gaustad, Alfred Halstensen, et al.. (1986). Preliminary results from a clinical trail with a meningococcal vaccine containing serotype 2b and 15 antigens in complex with mixed A, C, Y and W135 polysaccharides. Antonie van Leeuwenhoek. 52(3). 239–241. 4 indexed citations
2.
Winsnes, Randi, et al.. (1985). [Diphtheria and tetanus antitoxin levels. 5th grade elementary school pupils before and after revaccination].. PubMed. 105(31). 2202–6. 1 indexed citations
3.
Frøholm, L O, B. P. Berdal, K Bøvre, et al.. (1983). Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.. PubMed. 6(2). 133–8. 20 indexed citations
4.
How, M.J., et al.. (1971). ANTIBODY‐COMBINING OLIGOSACCHARIDES FROM A CHICK ALLANTOIC GLYCOPEPTIDE SULPHATE ASSOCIATED WITH INFLUENZA VIRUS HAEMAGGLUTININ. Acta Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology. 79B(3). 349–356. 3 indexed citations
5.
Harboe, Arild. (1971). [Influenza. Epidemiology and vaccination].. PubMed. 91(2). 110–3.
6.
Harboe, Arild, et al.. (1966). INFLUENZA VIRUS HI‐ANTIBODY COMBINING WITH NORMAL CHICK MATERIAL AND PRODUCED IN HENS IMMUNIZED WITH CHICK GROWN INFLUENZA VIRUS. Acta Pathologica Microbiologica Scandinavica. 68(1). 103–107. 3 indexed citations
7.
Ørstavik, I, et al.. (1966). [Epidemics caused by adenovirus in Norwegian military recruits].. PubMed. 86(14). 1045–7. 1 indexed citations
8.
Haukenes, Gunnar, et al.. (1966). A URONIC AND SIALIC ACID FREE CHICK ALLANTOIC MUCOPOLYSACCHARIDE SULPHATE WHICH COMBINES WITH INFLUENZA VIRUS HI‐ANTIBODY TO HOST MATERIAL. Acta Pathologica Microbiologica Scandinavica. 66(4). 510–518. 28 indexed citations
9.
Ørstavik, I, et al.. (1965). [Adenoviruses. A survey and a serological investigation among Norwegian soldiers].. PubMed. 85(9). 766–8.
10.
Harboe, Arild, et al.. (1964). PURIFICATION OF THE NORMAL ALLANTOIC ANTIGEN WHICH REACTS WITH INFLUENZA VIRUS HI—ANTIBODY TO HOST MATERIAL. Acta Pathologica Microbiologica Scandinavica. 60(2). 265–270. 11 indexed citations
11.
Harboe, Arild. (1963). The Influenza Virus Haemagglutination Inhibition By Antibody to Host Material. Acta Pathologica Microbiologica Scandinavica. 57(3). 317–330. 51 indexed citations
12.
Harboe, Arild. (1962). THE HETEROLOGOUS, ANAMNESTIC HI‐ANTIBODY INCREASE RESULTING FROM CROSS‐INFECTION WITH INFLUENZA A2 AND DUTCH ‘56 A1‐STRAINS. Acta Pathologica Microbiologica Scandinavica. 55(4). 415–424. 1 indexed citations
13.
Harboe, Arild, et al.. (1960). ANTIBODY CROSSABSORPTIONS BETWEEN INFLUENZA A2‐STRAINS. Acta Pathologica Microbiologica Scandinavica. 48(2). 133–139. 4 indexed citations
14.
Harboe, Arild, et al.. (1960). INFLUENZA A2‐STRAINS AGAINST A AND A1‐STRAINS IN CROSS‐HAEMAGGLUTINATION INHIBITION TESTS. Acta Pathologica Microbiologica Scandinavica. 48(3). 231–242. 7 indexed citations
15.
Harboe, Arild. (1958). The Course in Norway of the Influenza Pandemic caused by Virus of the Type A/Asia/57.. 60(48). 1 indexed citations
16.
Harboe, Arild, et al.. (1958). STUDIES ON FRANCIS INHIBITOR OF INFLUENZA VIRUS HAEMAGGLUTINATION IN RABBIT SERUM FRACTIONS OBTAINED BY ELECTROPHORESIS ON STARCH‐GRAIN. Acta Pathologica Microbiologica Scandinavica. 44(1). 92–105. 9 indexed citations
17.
Harboe, Arild, et al.. (1958). [Absenteeism of school children in Norwegian towns during Asian influenza epidemic].. PubMed. 78(18). 887–90. 1 indexed citations
18.
Harboe, Arild, et al.. (1958). Percentage of individuals presenting antibody to A/Asia/57 after an influenza outbreak in a military camp in October 1957. Archives of Virology. 8(4). 446–452. 2 indexed citations
19.
Harboe, Arild, et al.. (1957). The Complement Fixation Inhibition Test With Sera From Chickens Experimentally Infected With Toxoplasms. Acta Pathologica Microbiologica Scandinavica. 41(6). 511–516. 7 indexed citations
20.
Harboe, Arild. (1952). Toxoplasma dye test titers of 1600 blood donors in Oslo.. PubMed. 93. 325–31. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026